Type 2 Diabetes and the Brain in Adolescents
Dysglycemia & Obesity: Impact on the Brain in Adolescents With Type 2 Diabetes
1 other identifier
interventional
18
1 country
1
Brief Summary
This study evaluates differences in brain function and cognitive performance in adolescents with type 2 diabetes (T2D) compared to non diabetic controls (both obese and lean) and correlates these changes with obesity, insulin resistance, and glycemic control in youth with T2D.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable type-2-diabetes-mellitus
Started Dec 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 5, 2017
CompletedFirst Submitted
Initial submission to the registry
January 4, 2018
CompletedFirst Posted
Study publicly available on registry
March 12, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2019
CompletedSeptember 9, 2019
September 1, 2019
1.2 years
January 4, 2018
September 5, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Brain Activity using functional MRI (fMRI)
The investigators will examine functional connectivity of brain networks during cross sectional resting-state and task-related (working memory and response inhibition) BOLD-fMRI activation. fMRI activation in adolescents with T2D will be compared to age- and sex- matched, non-diabetic, healthy lean and obese controls.
Baseline
Neurocognitive battery metrics including IQ as well as executive function and visual-spatial memory
The investigators will evaluate cognitive performance by examining test scores from neurocognitive metrics which reflect global IQ, spatial recognition, episodic memory, executive function (includes response inhibition, working memory), academic achievement, and processing speed. Adolescents with T2D will be compared to controls to determine whether these differences are associated with glycemic control, obesity, and insulin resistance.
Baseline
fMRI performance in relation to dysglycemia
In adolescents with T2D, the investigators will examine BOLD-fMRI brain activation in relation to acute hyperglycemia during glucose clamping, chronic hyperglycemia, glycemic variability, and insulin resistance.
Baseline
Study Arms (3)
Type 2 Diabetes
EXPERIMENTALHyperglycemic clamp and Hyperinsulinemic Euglycemic clamp
Lean Control
NO INTERVENTIONControls do not undergo Hyperglycemic clamp and Hyperinsulinemic Euglycemic clamp
Obese Control
NO INTERVENTIONControls do not undergo Hyperglycemic clamp and Hyperinsulinemic Euglycemic clamp
Interventions
Subjects with T2D will receive IV Dextrose infusion to maintain plasma glucose at \~250 mg/dL during fMRI.
Subjects with T2D will receive IV Dextrose and Insulin infusion to maintain plasma glucose at approximately 90 mg/dL during fMRI.
Eligibility Criteria
You may qualify if:
- Type 2 Diabetes:
- BMI ≥85th percentile
- A1c ≥ 8%
- Pubertal
- Healthy Controls:
- BMI ≥85th percentile for Obese Controls
- BMI \< 85th percentile for Lean Controls
- Pubertal
- Normal A1c \& Fasting glucose
You may not qualify if:
- Significant developmental delay or learning disability
- Significant visual or auditory deficits
- Born \<34 weeks gestation
- Neurologic disease
- Psychiatric disease requiring inpatient treatment
- Significant head trauma
- Malignancy
- Pregnancy
- Weight \> 350lb (MRI weight limit)
- Metal in the body (including dental braces)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nemours Children's Health System
Jacksonville, Florida, 32207, United States
Related Publications (8)
Mazaika PK, Weinzimer SA, Mauras N, Buckingham B, White NH, Tsalikian E, Hershey T, Cato A, Aye T, Fox L, Wilson DM, Tansey MJ, Tamborlane W, Peng D, Raman M, Marzelli M, Reiss AL; Diabetes Research in Children Network (DirecNet). Variations in Brain Volume and Growth in Young Children With Type 1 Diabetes. Diabetes. 2016 Feb;65(2):476-85. doi: 10.2337/db15-1242. Epub 2015 Oct 28.
PMID: 26512024BACKGROUNDMauras N, Mazaika P, Buckingham B, Weinzimer S, White NH, Tsalikian E, Hershey T, Cato A, Cheng P, Kollman C, Beck RW, Ruedy K, Aye T, Fox L, Arbelaez AM, Wilson D, Tansey M, Tamborlane W, Peng D, Marzelli M, Winer KK, Reiss AL; Diabetes Research in Children Network (DirecNet). Longitudinal assessment of neuroanatomical and cognitive differences in young children with type 1 diabetes: association with hyperglycemia. Diabetes. 2015 May;64(5):1770-9. doi: 10.2337/db14-1445. Epub 2014 Dec 8.
PMID: 25488901BACKGROUNDMarzelli MJ, Mazaika PK, Barnea-Goraly N, Hershey T, Tsalikian E, Tamborlane W, Mauras N, White NH, Buckingham B, Beck RW, Ruedy KJ, Kollman C, Cheng P, Reiss AL; Diabetes Research in Children Network (DirecNet). Neuroanatomical correlates of dysglycemia in young children with type 1 diabetes. Diabetes. 2014 Jan;63(1):343-53. doi: 10.2337/db13-0179. Epub 2013 Oct 29.
PMID: 24170697BACKGROUNDBruehl H, Sweat V, Tirsi A, Shah B, Convit A. Obese Adolescents with Type 2 Diabetes Mellitus Have Hippocampal and Frontal Lobe Volume Reductions. Neurosci Med. 2011 Mar 1;2(1):34-42. doi: 10.4236/nm.2011.21005.
PMID: 21691448BACKGROUNDYau PL, Javier DC, Ryan CM, Tsui WH, Ardekani BA, Ten S, Convit A. Preliminary evidence for brain complications in obese adolescents with type 2 diabetes mellitus. Diabetologia. 2010 Nov;53(11):2298-306. doi: 10.1007/s00125-010-1857-y. Epub 2010 Jul 30.
PMID: 20668831BACKGROUNDYau PL, Kang EH, Javier DC, Convit A. Preliminary evidence of cognitive and brain abnormalities in uncomplicated adolescent obesity. Obesity (Silver Spring). 2014 Aug;22(8):1865-71. doi: 10.1002/oby.20801. Epub 2014 May 28.
PMID: 24891029BACKGROUNDCui Y, Jiao Y, Chen YC, Wang K, Gao B, Wen S, Ju S, Teng GJ. Altered spontaneous brain activity in type 2 diabetes: a resting-state functional MRI study. Diabetes. 2014 Feb;63(2):749-60. doi: 10.2337/db13-0519. Epub 2013 Dec 18.
PMID: 24353185BACKGROUNDMarder TJ, Flores VL, Bolo NR, Hoogenboom WS, Simonson DC, Jacobson AM, Foote SE, Shenton ME, Sperling RA, Musen G. Task-induced brain activity patterns in type 2 diabetes: a potential biomarker for cognitive decline. Diabetes. 2014 Sep;63(9):3112-9. doi: 10.2337/db13-1783. Epub 2014 Apr 4.
PMID: 24705405BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lydia Snyder, MD
Nemours Children's Health System
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
January 4, 2018
First Posted
March 12, 2018
Study Start
December 5, 2017
Primary Completion
January 30, 2019
Study Completion
January 30, 2019
Last Updated
September 9, 2019
Record last verified: 2019-09